focus -WSS

focus

author：fashion 2025-09-29 16:34:39 - browse：5978

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： FDA moves to stop vape shops from selling Elf Bar, Esco Bars

focus

WSS

Election results set back Medicaid expansion plans

Kansas bar where gunfire wounded 9 last month closes permanently

How dance can help nurses traumatized by Covid

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Sweden knocks USA out of World Cup in penalty kicks

How dance can help nurses traumatized by Covid

entertainment

focus

focus

Bright Health sells Medicare Advantage business to Molina

Custom gene therapy hints at new path for rare disease treatments

How one medical school became remarkably diverse

Google and Epic fight stronger regulation of AI in health care

Affirmative action in medical school literally saved lives

How dance can help nurses traumatized by Covid

Supreme Court strikes down use of affirmative action

Medicare has a new plan to address drug shortages

Medicare details structure of new drug price negotiation program

A public scorecard can help hold safety

focus

Doctors find melanoma drugs effective against rare brain cancer

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Sweden knocks USA out of World Cup in penalty kicks

'Brian's Song' at 50 still offers lessons about cancer for today

Election results set back Medicaid expansion plans

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

focus

knowledge

entertainment

focus